(Q38244094)

31 August 2017

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer (English)

1 reference

31 August 2017

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Paolo Dellabona

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Daniele Mennonna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Zlatko Trajanoski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Cristina Maccalli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Giorgio Parmiani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

28 August 2014

1 reference

Cancer Immunology, Immunotherapy

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

99-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164877%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-014-1599-7

6 June 2020

exact match

0 references

cites work

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

The makings of a tumor rejection antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Shaping the repertoire of tumor-infiltrating effector and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Unique tumor antigens redefined as mutant tumor-specific antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Heat shock proteins and their use as anticancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Discovery and saturation analysis of cancer genes across 21 tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Lessons from the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Unique human tumor antigens: immunobiology and use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Immune epitope database analysis resource (IEDB-AR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Epitope landscape in breast and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

HLA-binding properties of tumor neoepitopes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Bioinformatics for cancer immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1599-7